NCT06304207 Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease
| NCT ID | NCT06304207 |
| Status | Recruiting |
| Phase | — |
| Sponsor | MGH Institute of Health Professions |
| Condition | Copd |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2023-09-01 |
| Primary Completion | 2025-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2023-09-01 with a primary completion date of 2025-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this pilot clinical trial is to compare telehealth and onsite supervised maintenance exercise program for adults with Chronic Lung Disease. The specific aims of the study are: * To compare 8-week supervised maintenance program delivered onsite and via tele-rehab with no maintenance for patients with Chronic Lung Disease following discharge from traditional exercise or physical therapy or onsite outpatient rehabilitation programs on clinical outcomes (dyspnea, exercise capacity, physical function, physical activity, and quality of life) at 8 weeks and 4-months post-intervention. * To compare the differences in dyspnea, exercise capacity, physical function, physical activity, and quality of life between an 8-week maintenance program delivered onsite and via tele-rehab at 8-weeks and 4-months post-intervention in patients with Chronic Lung Disease following discharge from traditional onsite outpatient rehabilitation. Participants in both intervention groups (onsite and tele-rehab) will undergo a baseline onsite assessment followed by an 8-week supervised exercise intervention either onsite or in a telehealth setting. Control group will receive biweekly check in calls, but no active intervention.
Eligibility Criteria
Inclusion Criteria: * All adult patients 40 years and older with physician diagnosed Chronic Lung Disease within 2 months of discharge following completion of a traditional onsite outpatient rehabilitation or physical therapy or exercise program for their condition * Able to walk independently with or without mobility devices * Able to complete a six-minute walk test at discharge with or without supplemental oxygen maintaining an oxygen saturation at or above 85% * Able to follow commands and instructions in the English language * Have ability to connect to the internet Exclusion Criteria: * • Those with significant mobility limitations such as those with a history of stroke, neurological comorbidities such as Parkinson's disease or relapsing multiple sclerosis, or significant degenerative osteoarthritis, or any other joint impairments that compromise ability to walk independently with or without an assistive device. * Patients who primarily rely on a wheelchair for mobility * Patients with or without supplemental oxygen who are unable to complete a walking test without a drop in oxygen saturation to below 85% at discharge from traditional outpatient rehabilitation * Patients with baseline hemodynamic compromise, unstable angina, a recent myocardial infarction within a week, uncontrollable atrial fibrillation not managed with medications, advanced stage heart failure (New York Heart Association class 4), or those with mechanical circulatory assist devices for the heart such a ventricular assist device (VADs) * Inability to communicate in the English language
Contact & Investigator
Shweta Gore, PhD
PRINCIPAL INVESTIGATOR
MGH Institute of Health Professions
Frequently Asked Questions
Who can join the NCT06304207 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, studying Copd. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06304207 currently recruiting?
Yes, NCT06304207 is actively recruiting participants. Contact the research team at sgore@mghihp.edu for enrollment information.
Where is the NCT06304207 trial being conducted?
This trial is being conducted at Charlestown, United States.
Who is sponsoring the NCT06304207 clinical trial?
NCT06304207 is sponsored by MGH Institute of Health Professions. The principal investigator is Shweta Gore, PhD at MGH Institute of Health Professions. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.